Session Details

[D2-C2]ADA Round Table Discussion

Tue. Mar 4, 2025 3:25 PM - 6:00 PM JST
Tue. Mar 4, 2025 6:25 AM - 9:00 AM UTC
Large Conference Room 408(4th floor)
Chairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)

[D2-C2-01]Advancing Drug Development: Comprehensive and Optimum Approaches to the Immunogenicity Assessment (Round Table Discussion)

* (Chairpersons) Hiroyuki Shimizu1, *Hisanori Hara2 (1. Mitsubishi Tanabe Pharma Corporation, 2. B2S Life Sciences)

Q&A